LeanTaas CEO: EHRs are not built to handle capacity optimization

The latest stories trending on MedCity News.

Not rendering correctly? View this email as a web page here. TOP STORIES LeanTaas CEO: EHRs are not built to handle capacity optimization One of the biggest sources of patient dissatisfaction is waiting. LeanTaaS founder and CEO Mohan Giridharadas says hospitals are much better off using SaaS products embedded with sophisticated artificial intelligence to optimize their capacity rather than relying on their EHR capabilities or in-house data analysts if they want to see measurable results. SPONSORED Speaking the latest language of healthcare: Digital health tech From Amgen and MedCity News Pairing rheumatology expertise with the latest digital technologies, this app helps patients manage their treatment regimen with innovative and intuitive features. StartUPDATES: New developments from healthcare startups By Stephanie Baum Friday, May 27, 2022 7:47 AM Check out news from Memory Health, Equiva, KAID Health, Tegria, and Japa Health. Read more » MedCity Pivot podcast: Premier CEO believes more provider consolidation is necessary to achieve parity with payers By Arundhati Parmar Thursday, May 26, 2022 5:01 PM Mike Alkire talked about the importance of health systems achieving scale such that they are in a better position vis-a-vis payers who are typically much larger. Read more » It's time to integrate liquid biopsy into colorectal cancer treatment decision-making By Dr. Takayuki Yoshino Thursday, May 26, 2022 2:14 PM Since it measures the total amount of circulating DNA (ctDNA) in a patient's bloodstream using a simple blood draw, ctDNA liquid biopsy tests offers oncologists with an accurate, molecular, real-time cancer detection tool. It also helps to determine cancer staging and can help assess how aggressive the treatment regimen should be. Read more » New Flagship Pioneering startup expands the protein universe to fuel drug discovery By Frank Vinluan Thursday, May 26, 2022 11:32 AM ProFound Therapeutics emerged from stealth with technology that it claims has discovered tens of thousands of previously undiscovered proteins—many of them promising new drug targets. The Flagship Pioneering-founded startup is backed by $75 million to support its drug R&D along with plans to partner with large pharmaceutical companies. Read more » MedCity News   611 Broadway    New York,  NY   10012   United States You received this email because you are subscribed to MedCity Daily Digest from MedCity News. Update your email preferences to choose the types of emails you receive.  Unsubscribe from all future emails